fig.6.a,b

Rothe M et al. (2017)

Xla Wt + sipa1l3 MO

NF13 (in situ hybridization)

Expression Phenotype
decreased amount pax6.L expression in optic field decreased amount pax6.L expression in pre-chordal neural plate decreased amount rax.L expression in optic field decreased amount rax.L expression in pre-chordal neural plate

fig.6.e, f

Rothe M et al. (2017)

Xla Wt + sipa1l3 MO

NF23 (in situ hybridization)

Expression Phenotype
decreased amount pax6.L expression in optic vesicle decreased amount rax.L expression in optic vesicle

fig.7.d, e

Rothe M et al. (2017)

Xla Wt + sipa1l3 MO

NF23 (whole-mount microscopy)

Expression Phenotype
decreased amount pax6.L expression in optic vesicle decreased amount rax.L expression in optic vesicle

fig.2.h

Rothe M et al. (2017)

Xla Wt + sipa1l3 MO

NF42 (immunohistochemistry)

Anatomical Phenotype
abnormal development of lens abnormal lens morphology

cataract 45

fig.6.i, j, k

Rothe M et al. (2017)

Xla Wt + sipa1l3 MO

NF42 (immunohistochemistry)

Anatomical Phenotype
abnormal development of eye

fig.6.l, m, n

Rothe M et al. (2017)

Xla Wt + sipa1l3 MO

NF42 (immunohistochemistry)

Anatomical Phenotype
abnormal development of eye

fig.2.g

Rothe M et al. (2017)

Xla Wt + sipa1l3 MO

NF42 (in situ hybridization)

Anatomical Phenotype
abnormal retina morphology decreased size of the lens

fig.2.a

Rothe M et al. (2017)

Xla Wt + sipa1l3 MO

NF42 (whole-mount microscopy)

Anatomical Phenotype
abnormal development of lens abnormal eye morphology abnormal lens morphology abnormal retina morphology abnormal retinal pigmented epithelium morphology decreased size of the eye decreased size of the lens

fig.2.c, d

Rothe M et al. (2017)

Xla Wt + sipa1l3 MO

NF42 (whole-mount microscopy)

Anatomical Phenotype
abnormal eye morphology decreased size of the eye

fig.2.e, f

Rothe M et al. (2017)

Xla Wt + sipa1l3 MO

NF42 (whole-mount microscopy)

Anatomical Phenotype
decreased size of the lens